Emergent BioSolutions Inc. (EBS) NYSE

13.11

+0.26(+2.02%)

Updated at January 06 02:06PM

Currency In USD

Valuation

Market Cap506.68M
Enterprise Value1.08B
P/E Ratio9.01
PEG Ratio-0.2
Price/Sales Ratio0.88
Price/Book Ratio1.17
Enterprise/Revenue1.41
Enterprise/EBITDA5.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.15

Management Effectiveness

Return On Assets0.05
Return On Equity0.14

Income Statement

Revenue1.04B
Revenue/Share14.83
Gross Profit375.4M
EBITDA53.4M
Net Income-190.6M
Diluted EPS-3.6

Balance Sheet

Total Cash245.5M
Total Cash/Share4.61
Total Debt663.1M
Total Debt/Equity1.14
Current Ratio5.76
Book Value Per Share10.95

Price History

52-Week Change25.12
52-Week High13.41
52-Week Low4.02
Moving Average 50 Days11.21
Moving Average 200 Days8.03

Statistics

Average Volume1.04M
Shares Outstanding53.98M
% Held by Institutions76.96

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A